Questcor Pharmaceuticals, Inc. (QCOR)

[elbiatcho1]

10:04 Questcor CEO Calls Street Sweeper Article a 'Short Attack'
10:07 Questcor CEO Says Growth Driven by On-Label Sales and Strong Salesforce
10:14 Questcor CEO Says Next Growth Phase is From Use of Acthar in Lupus Patients
10:18 Questcor Pharma CEO Sees Acthar Market Oppotunity $2B+
10:33 (Dow Jones) Questcor (QCOR) didn't elaborate further on a negative report expected to be published by the blog Street Sweeper next week. At a healthcare conference Thursday, company reiterated a statement it previously issued in defending its marketing practices. "We really don't want to get distracted with this particular issue," said CEO Don Bailey . "We're here today to talk about QCOR and its value proposition for investors." QCOR shares down 2.2% to $34.56 .